These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7752828

  • 1. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.
    Langsjoen H, Langsjoen P, Langsjoen P, Willis R, Folkers K.
    Mol Aspects Med; 1994; 15 Suppl():s165-75. PubMed ID: 7752828
    [Abstract] [Full Text] [Related]

  • 2. Treatment of essential hypertension with coenzyme Q10.
    Langsjoen P, Langsjoen P, Willis R, Folkers K.
    Mol Aspects Med; 1994; 15 Suppl():S265-72. PubMed ID: 7752851
    [Abstract] [Full Text] [Related]

  • 3. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
    Davini A, Cellerini F, Topi PL.
    Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
    [Abstract] [Full Text] [Related]

  • 4. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.
    Soongswang J, Sangtawesin C, Durongpisitkul K, Laohaprasitiporn D, Nana A, Punlee K, Kangkagate C.
    Pediatr Cardiol; 2005 Nov; 26(4):361-6. PubMed ID: 16374685
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypertrophic cardiomyopathy with coenzyme Q10.
    Langsjoen PH, Langsjoen A, Willis R, Folkers K.
    Mol Aspects Med; 1997 Nov; 18 Suppl():S145-51. PubMed ID: 9266516
    [Abstract] [Full Text] [Related]

  • 6. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U, Rossi E, Littarru GP, Frustaci A, Lippa S, Oradei A, Aureli V.
    Int J Tissue React; 1990 Nov; 12(3):173-8. PubMed ID: 2276896
    [Abstract] [Full Text] [Related]

  • 7. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment.
    Langsjoen PH, Langsjoen PH, Folkers K.
    Clin Investig; 1993 Nov; 71(8 Suppl):S140-4. PubMed ID: 8241699
    [Abstract] [Full Text] [Related]

  • 8. Overview of the use of CoQ10 in cardiovascular disease.
    Langsjoen PH, Langsjoen AM.
    Biofactors; 1999 Nov; 9(2-4):273-84. PubMed ID: 10416041
    [Abstract] [Full Text] [Related]

  • 9. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
    Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P.
    Klin Wochenschr; 1988 Jul 01; 66(13):583-90. PubMed ID: 3062263
    [Abstract] [Full Text] [Related]

  • 10. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P.
    Int J Tissue React; 1990 Jul 01; 12(3):163-8. PubMed ID: 2276894
    [Abstract] [Full Text] [Related]

  • 11. Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: echocardiographic study.
    Oda T.
    Mol Aspects Med; 1994 Jul 01; 15 Suppl():s149-54. PubMed ID: 7752826
    [Abstract] [Full Text] [Related]

  • 12. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.
    Mortensen SA.
    Biofactors; 2003 Jul 01; 18(1-4):79-89. PubMed ID: 14695923
    [Abstract] [Full Text] [Related]

  • 13. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.
    Salles JE, Moisés VA, Almeida DR, Chacra AR, Moisés RS.
    Diabetes Res Clin Pract; 2006 Apr 01; 72(1):100-3. PubMed ID: 16253379
    [Abstract] [Full Text] [Related]

  • 14. Coenzyme Q10 as Adjunctive Therapy for Cardiovascular Disease and Hypertension: A Systematic Review.
    Sue-Ling CB, Abel WM, Sue-Ling K.
    J Nutr; 2022 Jul 06; 152(7):1666-1674. PubMed ID: 35348726
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardiomyopathy: assessment by iodine-123 labelled 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid myocardial single-photon emission tomography.
    Kim Y, Sawada Y, Fujiwara G, Chiba H, Nishimura T.
    Eur J Nucl Med; 1997 Jun 06; 24(6):629-34. PubMed ID: 9169569
    [Abstract] [Full Text] [Related]

  • 16. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
    Folkers K, Langsjoen P, Langsjoen PH.
    Biochem Biophys Res Commun; 1992 Jan 15; 182(1):247-53. PubMed ID: 1731784
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effects of coenzyme Q10 on dilated cardiomyopathy: assessment by 123I-BMIPP myocardial single photon emission computed tomography (SPECT): a multicenter trial in Osaka University Medical School Group].
    Nishimura T, Hori M.
    Kaku Igaku; 1996 Jan 15; 33(1):27-32. PubMed ID: 8819712
    [Abstract] [Full Text] [Related]

  • 18. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP, Q-SYMBIO Study Investigators.
    JACC Heart Fail; 2014 Dec 15; 2(6):641-9. PubMed ID: 25282031
    [Abstract] [Full Text] [Related]

  • 19. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators.
    Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G.
    Mol Aspects Med; 1994 Dec 15; 15 Suppl():s287-94. PubMed ID: 7752841
    [Abstract] [Full Text] [Related]

  • 20. Effect of coenzyme Q10 on stress-induced cardiac dysfunction in paediatric patients with mitral valve prolapse: a study by stress echocardiography.
    Oda T.
    Drugs Exp Clin Res; 1985 Dec 15; 11(8):557-76. PubMed ID: 3836874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.